OBJECTIVES: To assess the prevalence and clinical significance of elevated ankle-brachial index (ABI) in patients referred to vascular consultation. DESIGN: Retrospective clinical study. MATERIAL AND METHODS: In 1,762 patients referred with a suspicion of peripheral arterial disease (PAD), ABI and toe brachial index (TBI) were measured by photoplethysmography. ABI>/=1.3 was considered falsely elevated and TBI<0.60 was the diagnostic criterion for PAD. RESULTS: The prevalence of elevated ABI was 8.4% and that of PAD among these patients 62.2%. PAD was significantly more prevalent among subjects with severe symptoms (rest pain, ulcers or gangrene) than in those with intermittent claudication (83.8% and 45.3%, respectively, p<0.001). The risk of PAD diagnosis was ten-fold (OR 10.31, 95% CI 2.07-51.30) among those with chronic renal failure, five-fold among patients with a history of smoking (OR 5.63, 95% CI 1.22-26.00) and over three-fold (OR 3.44, 95% CI 1.46-8.12) among those with coronary heart disease. The specificities of elevated ABI threshold levels (1.3, 1.4 and 1.5) in identifying PAD were 86%, 94% and 96%, respectively, the sensitivities being 44%, 38% and 36%, respectively. CONCLUSIONS: The prevalence of elevated ABI in patients referred to vascular consultation is 8.4% and that of PAD among these 62.2%. PAD is significantly more probable among those with chronic renal failure, a history of smoking and coronary heart disease. Furthermore, the specificity of elevated ABI (>/=1.3) in recognizing PAD is good, whereas the sensitivity is only satisfactory.
OBJECTIVES: To assess the prevalence and clinical significance of elevated ankle-brachial index (ABI) in patients referred to vascular consultation. DESIGN: Retrospective clinical study. MATERIAL AND METHODS: In 1,762 patients referred with a suspicion of peripheral arterial disease (PAD), ABI and toe brachial index (TBI) were measured by photoplethysmography. ABI>/=1.3 was considered falsely elevated and TBI<0.60 was the diagnostic criterion for PAD. RESULTS: The prevalence of elevated ABI was 8.4% and that of PAD among these patients 62.2%. PAD was significantly more prevalent among subjects with severe symptoms (rest pain, ulcers or gangrene) than in those with intermittent claudication (83.8% and 45.3%, respectively, p<0.001). The risk of PAD diagnosis was ten-fold (OR 10.31, 95% CI 2.07-51.30) among those with chronic renal failure, five-fold among patients with a history of smoking (OR 5.63, 95% CI 1.22-26.00) and over three-fold (OR 3.44, 95% CI 1.46-8.12) among those with coronary heart disease. The specificities of elevated ABI threshold levels (1.3, 1.4 and 1.5) in identifying PAD were 86%, 94% and 96%, respectively, the sensitivities being 44%, 38% and 36%, respectively. CONCLUSIONS: The prevalence of elevated ABI in patients referred to vascular consultation is 8.4% and that of PAD among these 62.2%. PAD is significantly more probable among those with chronic renal failure, a history of smoking and coronary heart disease. Furthermore, the specificity of elevated ABI (>/=1.3) in recognizing PAD is good, whereas the sensitivity is only satisfactory.
Authors: Suzanne Hyun; Nketi I Forbang; Matthew A Allison; Julie O Denenberg; Michael H Criqui; Joachim H Ix Journal: J Vasc Surg Date: 2014-03-21 Impact factor: 4.268
Authors: Simon Hsu; Dena E Rifkin; Michael H Criqui; Natalie C Suder; Pranav Garimella; Charles Ginsberg; Antoinette M Marasco; Belinda J McQuaide; Emma J Barinas-Mitchell; Matthew A Allison; Christina L Wassel; Joachim H Ix Journal: J Vasc Surg Date: 2017-12-22 Impact factor: 4.268
Authors: Ali F AbuRahma; Elliot Adams; Joseph AbuRahma; Luis A Mata; L Scott Dean; Cristyn Caron; Jennifer Sloan Journal: J Vasc Surg Date: 2019-08-27 Impact factor: 4.268
Authors: Himabindu Vidula; Kiang Liu; Michael H Criqui; Moyses Szklo; Matthew Allison; Christopher Sibley; Pamela Ouyang; Russell P Tracy; Cheeling Chan; Mary M McDermott Journal: Atherosclerosis Date: 2015-09-03 Impact factor: 5.162
Authors: Joachim H Ix; Ronit Katz; Carmen A Peralta; Ian H de Boer; Matthew A Allison; David A Bluemke; David S Siscovick; João A C Lima; Michael H Criqui Journal: J Am Coll Cardiol Date: 2010-01-26 Impact factor: 24.094
Authors: Maria Teresa B Abola; Jonathan Golledge; Tetsuro Miyata; Seung-Woon Rha; Bryan P Yan; Timothy C Dy; Marie Simonette V Ganzon; Pankaj Kumar Handa; Salim Harris; Jiang Zhisheng; Ramakrishna Pinjala; Peter Ashley Robless; Hiroyoshi Yokoi; Elaine B Alajar; April Ann Bermudez-Delos Santos; Elmer Jasper B Llanes; Gay Marjorie Obrado-Nabablit; Noemi S Pestaño; Felix Eduardo Punzalan; Bernadette Tumanan-Mendoza Journal: J Atheroscler Thromb Date: 2020-07-04 Impact factor: 4.928
Authors: Jerry Meng; Christina L Wassel; Bryan R Kestenbaum; Tracie C Collins; Michael H Criqui; Cora E Lewis; Steve R Cummings; Joachim H Ix Journal: Am J Epidemiol Date: 2010-03-17 Impact factor: 4.897
Authors: Michael H Criqui; Robyn L McClelland; Mary M McDermott; Matthew A Allison; Roger S Blumenthal; Victor Aboyans; Joachim H Ix; Gregory L Burke; Kaing Liu; Steven Shea Journal: J Am Coll Cardiol Date: 2010-10-26 Impact factor: 24.094
Authors: Joachim H Ix; Ronit Katz; Ian H De Boer; Brian R Kestenbaum; Matthew A Allison; David S Siscovick; Anne B Newman; Mark J Sarnak; Michael G Shlipak; Michael H Criqui Journal: J Am Coll Cardiol Date: 2009-09-22 Impact factor: 24.094